CONCLUSIONS
The aim of this prognostic assessment tool is the identification of
high-risk pregnancies among those with an sFlt-1/PlGF ratio above 38.
This prognostic assessment tool includes NT-proBNP, which is a cardiac
damage marker that has been identified as a pre-eclampsia prognosis
predictor using a study design that allows repeated measurements. In
this context, we do not recommend assessing pregnancy prognosis solely
using sFlt-1/PlGF ratio raw values as there seems to be better
alternatives.